se of the closure device in patient with percutaneous transfemoral aortic valve replacement
Not Applicable
- Conditions
- HIGH GRADE AORTIC VALVE STENOSIS
- Registration Number
- DRKS00030588
- Lead Sponsor
- niversitätsklinikum der RWTH Aachen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
1. Patient scheduled for treatment with the TAVR device
2. Decision to use the Manta or the Prostar closure device on a clinical base by the treating physician
3. Signed informed consent
Exclusion Criteria
Male or female aged < 18
Pregnant and lactating females
Patient has been committed to an institution by legal or regulatory order
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Feasibility and Safety of the closure device in TAVR patients
- Secondary Outcome Measures
Name Time Method